These links are in alphabetical order and are not sponsored:
Veterinary Pharmaceuticals Companies
Boehringer-Ingelheim (https://www.boehringer-ingelheim.co.uk/animal-health/animal-health). Manufacture the only essential fatty acid supplement that I recommend – Viacutan Plus®. B-I have recently taken over Merial Animal Health Ltd. adding two separate ranges of ectoparasiticidal products to their portfolio.
A specific website, including a fun YouTube video, dedicated to the extensive range of Douxo® dermatological topicals designed to help all types of skin problems for dogs and cats. The entire Douxo S3® range, which is divided into four main categories (Pyo, Seb, Calm, Care), contains Ophytrium® extract from the root of Ophiopogon japonicus (monkey grass) that restores, replenishes and re-balances the three skin barriers (mechanical, immunological, microbiological). Other ingredients include chlorhexidine, panthenol (B5), niacinamide (B3), pentavitin, Simmondsia chinensis (jojoba) and Punica granulatum (pomegranate) extracts. These innovative topicals are available as shampoos, mousses, sprays, pads and serum, which aids greatly with owner & patient compliance! See testimonial below.
In Autumn 2019, Ceva held a pre-Congress launch event at the 31st ESVD Congress in Liverpool, for their new Douxo S3 range. The range has now been launched featuring the new ingredient Ophytrium®, revised & less labour intensive treatment protocols, ergonomic packaging plus improved texture and fragrances: Douxo S3 Pet Owner Leaflet (Ceva) plus the Douxo User Guide & Protocols (Ceva)
This brochure contains a wealth of information including brochures, publications, case studies, reward cards, How to… videos etc. etc.: Douxo S3 – Journey So Far Interactive Brochure
Incredibly some corporate prescribing restrictions ban the use of this innovative range throughout their clinics depriving their clients & pet parents from treating their pets with these ground-breaking topicals.
Many clients searching this website will be aware that: Otitis is not a quick fix (Dechra), so take a look at the dedicated web site for the commonest worldwide ailment of our canine companions – otitis externa – introduced in Lifelong Ear Partnership (Dechra) plus a useful Ear Diary (Dechra) for logging any treatment regimen
Elanco took over Novartis Animal Health UK Ltd, who were responsible for the research and development of the potent targeted anti-inflammatory molecule cyclosporinA (Atopica®).
Three articles, published to mark Atopica®‘s tenth birthday in 2014, are available free through the Vet Record (the journal of the British Veterinary Association) website: http://veterinaryrecord.bmj.com/ Search for: ‘Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis’, ‘Ciclosporin in canine dermatology: a decade of comfort’ and ‘Ciclosporin 10 years on: treatment and efficacy’. At time of publication, over 150 million doses had been prescribed worldwide.
The latest Vet detailer for those that like more scientific references: Atopica Vet Detailer (Cat & Dog)
Produces established and new, innovative anti-parasite medications for companion animals. It also runs mypetonline website – an ‘online community where vets, pets and owners come together’ including a postcode specific ‘Diseases in My Area’ search facility (http://www.mypetonline.co.uk/pet-health)
Vetruus have also launched a variety of topical products which contain the first licensed veterinary antimicrobial peptide, AMP 2041, heralding a new era in veterinary antimicrobial treatment: Peptivet Oto Gel (Vetruus)
Free Dermatology webinars: https://artuvet.com/en/for-veterinary-clinics/education/
Further information on intradermal allergy testing and Artuvetrin, injectable and sublingual, allergen-specific immunotherapy treatment for Atopic (aeroallergen allergic) pets from the premier European allergy company, for both vets and clients Allergy in Dogs (ArtuVet Client Brochure), Immunotherapy Injection Technique (ArtuVet, Nextmune), Immunotherapy Treatment Diary (ArtuVet, Nextmune), Sublingual Immunotherapy (ArtuVet, Nextmune)
Their full resource library can be found at: https://nextmune.com/document-library/
Their revolutionary veterinary-specific, anti-itching drug Apoquel® (oclacitinib), a janus kinase inhibitor, released in early 2014 sold out within weeks due to high demand worldwide: Apoquel Client Leaflet, Oclacitinib, JAK Inhibitor (Zoetis)
In Summer 2017, I was lucky to be selected to participate in the Early Experience Programme for Zoetis’ future next launch – Cytopoint® – the first monoclonal antibody for canine atopic dermatitis! As a key opinion leader, I was excited to have been given access to this medication before it was fully released into the UK.
Here is some more information on this revolutionary monthly injectable biologic which gives targetted, fast and sustained relief for atopic dogs: Client Leaflet Cytopoint, Lokivetmab, vs IL31, Zoetis.